Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from RBC Capital
RBC Capital analyst Luca Issi maintained a Buy rating on Lexeo Therapeutics, Inc. (LXEO – Research Report) on November 13 and set a price ...
Promising Developments in Lexeo Therapeutics’ LX2006 Program Drive Buy Rating
In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Lexeo Therapeutics, Inc. (LXEO – Research ...